Animal Cognition
Fundamentals, Models, and Therapeutic Advances
- 1st Edition - July 1, 2026
- Latest edition
- Editors: Shampa Ghosh, Jitendra Kumar Sinha, Niraj Kumar Jha, Rakesh Bhaskar
- Language: English
Animal Cognition: Fundamentals, Models, and Therapeutic Advances is a research volume covering foundational research in animal cognition. This book provides a comprehensive overvi… Read more
- Explains cognitive similarities and differences across species
- Offers practical applications for cognitive findings
- Integrates theoretical concepts with advanced therapeutic practices
- Provides multidisciplinary perspectives from leading experts in the field
1. Introduction to Cognitive Processes in Animals
2. Evolution of Cognition
Section 2: Cognitive Mechanisms in Animal Models
3. Mammalian Cognition
4. Avian Intelligence: From Problem-Solving to Social Dynamics
5. Cognitive Studies in Marine Animals
6. Cognition in Reptiles and Amphibians
7. Cognitive Insights from Insects
Section 3: Advanced Topics and Therapeutics
8. Therapeutic Applications of Cognitive Research in Animals
9. Emerging Technologies in Cognitive Studies
10. Research Gaps and Future Perspectives
- Edition: 1
- Latest edition
- Published: July 1, 2026
- Language: English
SG
Shampa Ghosh
JS
Jitendra Kumar Sinha
Dr. Jitendra Kumar Sinha, PhD, is the Chief Scientific Officer at GloNeuro Academy, Noida and Neuroscience Visiting Faculty at Jiwaji University, Gwalior, India. His research interests include the neurobiology of aging and obesity, nutritional neuroscience, anti-aging paradigms and neuropharmacology. He has over 16 years experience in research and education, including high level course development and mentorship. He has a long-standing interest in animal models of aging and epilepsy, with focus on oxidative protein damage, DNA damage, and aging biomarkers, and notably established the heaviest rodent model for studying molecular mechanism of enhanced aging. Dr. Sinha has authored over 70 publications in several leading journals on aging, epilepsy, obesity, sleep, and spinal cord injury. He has served as guest editor, referee, or member of the editorial board for over 25 journals and received various prestigious awards from Government of India, International Brain Research Organization, International Society for Neurochemistry, among others.
NJ
Niraj Kumar Jha
Dr. Niraj Kumar Jha is an assistant professor in the Department of Biotechnology at Sharda University, Greater Noida, India, and a member of the Royal Society of Biology, London. Previously, he served as an assistant professor at the Noida Institute of Engineering and Technology, affiliated with Abdul Kalam Technical University. He holds an MSc in Biotechnology from Vellore Institute of Technology and a Ph.D. in Biotechnology from Delhi Technological University, supported by a research fellowship from the Department of Biotechnology, Government of India. A prolific author, Dr. Jha has published over 150 scholarly works and presented his research at international conferences. He currently serves as an associate editor for IET Nanobiotechnology and guest editor for several high-impact journals. His research interests focus on the pathogenesis of neurodegenerative, cancer, respiratory, and cardiovascular diseases, as well as the therapeutic roles of small molecules from natural or synthetic sources.
RB
Rakesh Bhaskar
Dr. Rakesh Bhaskar is an Assistant Professor at Yeungnam University, South Korea. He holds a Ph.D. in Neuroendocrinology from Allahabad University, India, and has extensive research experience in aging biology, regenerative medicine, and cognitive neurosciences. His work explores molecular mechanisms underlying cellular senescence, stem cell-based therapies, and tissue engineering approaches for age-associated conditions. Dr. Bhaskar has published over 80 scientific articles in high-impact journals, holds two patents, and has contributed to multiple book chapters. He also serves as a reviewer for leading international journals. His research focuses on developing innovative biomaterials and therapeutic interventions to enhance healthspan and combat age-related degenerative diseases.